Infertility affects 1 in 5 people, yet IVF remains costly and inconsistent. MIM Fertility provides evidence-based AI solutions to enhance decision-making, standardize care, and lower costs, improving accessibility.
We applied for AI FOR IVF funding to support marketing and ensure trust in our SaMD-certified AI. Backed by an international Scientific Advisory Board, our technology remains rigorous, validated, and clinically aligned.
Key Project Objectives
1. Establishing a Scientific Advisory Board (SAB):
AI adoption in IVF requires trust and credibility. The SAB consists of globally recognized reproductive medicine specialists who oversee and advise on AI implementation. The SAB members serve as project ambassadors, actively promoting our solutions and shaping the future of AI in IVF.
2. Building and Executing an Expert-Authored Content Marketing Strategy:
Content marketing is the most effective B2B engagement tool, fostering education and market trust. We developed a comprehensive strategy in collaboration with the SAB and industry experts, addressing common concerns, questions, and key talking points. This included creating expert-led blog content, launching the AI Academy, AI workshops, and producing educational materials to prepare and support the industry’s AI transition. As AI in IVF is still an emerging field, this initiative aims to educate, shift mindsets, and drive industry adoption.
3. Developing a Motivational Branding Strategy for Global Markets:
Introducing AI in IVF requires more than awareness—it demands daily integration into clinical practice. Our targeted branding approach positions AI as essential, not optional, through specialized messaging and dedicated communication channels. A strong presence at key industry events (e.g. ESHRE, ASRM) further reinforces AI’s real-world impact and builds trust among fertility professionals.
AI adoption in healthcare is a paradigm shift that necessitates support for professionals. Given the mental health burden in IVF, AI can reduce stress by alleviating workload and decision fatigue. However, technology alone is insufficient—trust, communication, and ongoing support are critical. Our compassionate strategy ensures AI is introduced in a way that resonates with the human side of fertility care, fostering both confidence and long-term adoption.
4.Building a Business Development Team for Market Penetration:
While marketing, content strategy, event participation, and communication create demand, a dedicated business development team is necessary to convert interest into sales. Our market research and strategic execution plan identified high-potential markets for AI adoption. A trained business development team ensures direct engagement with clinics, demonstrating how AI solutions improve workflows and patient success rates.
